The study by Ricci et al. examined the activity of MMP-2 and MMP-9 in the sera of brain tumor patients (gliomas, meningiomas, and metastases) compared to healthy controls using zymography and immunohistochemistry. This evidence concerns the gene MMP9 and glioma.